Healthcare Prenetics Reports Record Q4 and FY2025 Revenue; Guides for 2026 Growth 2 weeks ago Prenetics Global Limited (NASDAQ: PRE), a health sciences company, reported record financial results for the fourth quarter and full fiscal… Insulet Corporation Reports 31% Annual Revenue Growth; Authorizes $350 Million Repurchase Increase 2 weeks ago The global medical technology leader exceeded 2025 financial targets behind a 44% surge in international sales and the expansion of… Charles River Laboratories (CRL) Q4 revenue, adjusted earnings top expectations 2 weeks ago Charles River Laboratories International, Inc. (NYSE: CRL), a provider of products and services for pharma companies to accelerate drug discovery… AtriCure reports surprise Q4 profit on strong worldwide revenue growth 2 weeks ago Shares of AtriCure, Inc. (Nasdaq: ATRC) rose 6.4% to $34.12 in Wednesday morning trading after the medical device maker reported… Beta Bionics Shares Edge Higher After Q4 Revenue Jumps 57%, Full-Year Sales Top $100 Million 2 weeks ago Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday, up about… cbdMD reports narrowed Q1 net loss, issues going-concern warning 2 weeks ago Shares of cbdMD, Inc. (NYSE YCBD) rose 10.72% to $0.78 in Tuesday afternoon trading following the release of its fiscal… Genmab Q4 2025 Earnings Report: Innovation Push Drives Profit Surge 2 weeks ago Genmab A/S (Nasdaq: GMAB) released its full-year 2025 financial results, demonstrating the company's improved operational execution. Total revenue reached $3.72… WAY Shares Close at $24.29 After Waystar Reports Q4 2025 Results 2 weeks ago Waystar Holding Corp (Nasdaq: WAY) shares closed at $24.29 at the latest U.S. market close following the company’s fourth-quarter and… Earnings Summary – Labcorp Reports Fourth Quarter and Full Year 2025 Results and Issues 2026 Guidance 2 weeks ago Labcorp Holdings Inc. (NYSE: LH), a global leader in laboratory services, released financial results for the fourth quarter and full… NeoGenomics Full Year 2025 Revenue Rises to $727 Million 2 weeks ago NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full… Next» « Previous